Mass General Brigham looks to cancer care without Dana-Farber

The CEO of Mass General Brigham told STAT that the $20 billion nonprofit hospital system is ready to move on without Dana-Farber.

April 15, 2024 Check out STAT+

Sponsored By

The Boston Globe STAT+ | Mass General Brigham is ready to move on without Dana-Farber, CEO says Anne Klibankski talks about cancer care after MGB's impending split with Dana-Farber, the cost of services, and moves by UnitedHealth. By Bob Herman STAT+ | Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition The company's drug was generally safe and led to rapid and clinically meaningful improvements in cognition, communication, and sleep. By Allison DeAngelis Opinion: Hospitals that make profits should pay taxes Most hospitals pay no taxes. The IRS community benefit standard allows nonprofit hospitals to inflate charity care, avoid taxes. By Marty Makary Mike Reddy for STAT STAT+ | Can investing in infectious disease pay off? Vir Biotechnology's tightrope walk shows it's a struggle In 2017, Vir's founders threw millions at infectious disease. Covid made them look like geniuses. The road since then has been far rockier. By Jason Mast Opinion: ADHD is often overlooked in girls and women. They need help, too It is harder for girls and women to access appropriate ADHD diagnosis and treatment, and shortages of medication further reduce access. By Michael Morse and Kathleen Nadeau

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser